Latest Biotech News

Global pharmaceutical companies continue to undergo significant leadership changes and strategic restructurings. GSK announced the departure of CEO Emma Walmsley, marking the end of her nine-year...

Genmab announced an $8 billion acquisition of Merus to gain full ownership of the latter's late-stage bispecific antibody, petosemtamab, targeting head and neck cancer. This acquisition aligns...

Pfizer has become the first drugmaker to agree to implement a most-favored nation (MFN) pricing agreement, matching U.S. prices to comparable developed nations. The agreement includes launching a...

Revolution Medicines has appointed a new executive with extensive experience at Mirati and ALX as part of their leadership expansion. This strategic hire strengthens the company's operational...

Recent NRG Oncology clinical trials have yielded significant findings across multiple cancer types. The NRG-BN001 trial demonstrated enhanced survival in glioblastoma patients treated with proton...

Advancements in artificial intelligence and machine learning are driving transformative tools in drug discovery and biomedical data analysis. Cadence Molecular Sciences launched ROCS X, an...

Cutting-edge research reveals new immunotherapeutic strategies for challenging cancers. Climb Bio reported promising preclinical data for CLYM116, an anti-APRIL antibody showing deeper IgA...

Researchers are pioneering advanced nucleic acid technologies with impactful biotech applications. A novel massively parallel DNA synthesis system using microchip technology promises large-scale...

Emerging therapies are tackling complex inflammatory and metabolic disorders with innovative approaches. Obefazimod, a selective miR-124 enhancer, shows clinical responses in ulcerative colitis...

The biotech and pharmaceutical industry is witnessing important leadership transitions and regulatory evolutions. GSK announced Emma Walmsley’s departure as CEO, with Luke Miels set to succeed...

Recent studies are elucidating complex biological mechanisms to inform disease treatment. Discoveries include the role of SET8 protein in enhancing prognosis and radiotherapy in lung...

Genmab has agreed to acquire Dutch biotech Merus for approximately $8 billion in a deal designed to bolster its cancer treatment pipeline with a late-stage bispecific antibody, petosemtamab. The...

Pfizer has become the first pharmaceutical company to agree to the Trump administration’s most-favored nation (MFN) drug pricing policy, committing to price its products in the U.S. in line with...

Several breakthroughs highlight artificial intelligence and computational innovations transforming biotechnology and medical diagnostics. A new AI-driven framework automates lymph node...

Multiple significant clinical trial results have emerged across oncology disciplines. NRG Oncology’s Phase II data shows proton therapy combined with emission correlates with enhanced survival in...

Recent studies provide significant insights into neurological disorders and brain health. Research into Parkinson’s disease reveals thalamic volume shifts correlating with cognitive and motor...

Groundbreaking research is elucidating the origins and functional evolution of CRISPR systems critical to genome editing technology. A new study reveals an RNA splitting mechanism that drove the...

Emerging research highlights profound interactions between drug use and microbiome dynamics with implications for diagnostics and treatment. A large Estonian cohort study found that various...

Radiation oncology is witnessing technological advances improving cancer treatment efficacy and patient quality of life. A decade-long trial reveals that stereotactic radiation therapy matches...

Research in materials science and energy storage has yielded transformative innovations potentially impacting future sustainable technologies. Advances include the development of recyclable...